Hefei Hengxin Life Science and Technology Co., Ltd. (SHE:301501)
China · Delayed Price · Currency is CNY 33.68
+0.11 (0.33%)
May 7, 2026, 3:04 PM CST
SHE:301501 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 183.03 | 232.6 | 219.89 | 213.86 | 162.77 | 80.16 |
Depreciation & Amortization | 109.28 | 109.28 | 75.78 | 50.22 | 38.36 | 27.2 |
Other Amortization | 3.7 | 3.7 | 3.62 | 2.61 | 2.5 | 1.09 |
Loss (Gain) From Sale of Assets | -0.34 | -0.34 | -0.88 | 0.3 | -0.24 | -0.05 |
Asset Writedown & Restructuring Costs | 4.75 | 4.75 | 0.51 | 2.41 | 1.17 | 0.01 |
Loss (Gain) From Sale of Investments | -1.04 | -1.04 | 0 | 2.14 | 5.5 | 11.24 |
Provision & Write-off of Bad Debts | - | - | 0.88 | 3.23 | 2.13 | 0.42 |
Other Operating Activities | 64.12 | 8.13 | 14.43 | 15.79 | 9.07 | 6.18 |
Change in Accounts Receivable | -32.24 | -32.24 | -16.22 | -71.51 | -44.84 | -29.66 |
Change in Inventory | -84.4 | -84.4 | 11.94 | -30.63 | -52.86 | -27.74 |
Change in Accounts Payable | 86.41 | 86.41 | 76.78 | 37.93 | 171.37 | 74.09 |
Change in Other Net Operating Assets | 0.15 | 0.15 | 0.75 | 0.67 | 0.19 | - |
Operating Cash Flow | 345.97 | 339.55 | 380.86 | 219.49 | 292.65 | 143.85 |
Operating Cash Flow Growth | 7.04% | -10.85% | 73.52% | -25.00% | 103.44% | 344.81% |
Capital Expenditures | -527.8 | -527.95 | -459.69 | -330.35 | -290.07 | -134.1 |
Sale of Property, Plant & Equipment | 2.55 | 2.54 | 0.05 | 0.37 | 0.56 | 0.8 |
Investment in Securities | -365 | -415 | - | - | 0.01 | - |
Other Investing Activities | 3.97 | 2.24 | - | - | 0 | -1.19 |
Investing Cash Flow | -886.28 | -938.17 | -459.64 | -329.98 | -289.49 | -134.49 |
Long-Term Debt Issued | - | 100 | 279.49 | 153.64 | 196.99 | 12.35 |
Total Debt Issued | 85 | 100 | 279.49 | 153.64 | 196.99 | 12.35 |
Long-Term Debt Repaid | - | -291.26 | -119.1 | -82.78 | -55.25 | -35 |
Total Debt Repaid | -262.42 | -291.26 | -119.1 | -82.78 | -55.25 | -35 |
Net Debt Issued (Repaid) | -177.42 | -191.26 | 160.39 | 70.85 | 141.74 | -22.65 |
Issuance of Common Stock | - | 934.82 | - | - | - | 52.56 |
Common Dividends Paid | -56.95 | -58.78 | -11.4 | -7.63 | -19.46 | -9.74 |
Other Financing Activities | -67.79 | -82.07 | -6.32 | -5.51 | -15.14 | -13.27 |
Financing Cash Flow | -302.17 | 602.7 | 142.67 | 57.72 | 107.14 | 6.9 |
Foreign Exchange Rate Adjustments | -11.51 | 9.63 | 10.77 | 3.18 | 3.21 | -1.3 |
Net Cash Flow | -853.99 | 13.72 | 74.66 | -49.59 | 113.51 | 14.97 |
Free Cash Flow | -181.84 | -188.4 | -78.83 | -110.86 | 2.58 | 9.75 |
Free Cash Flow Growth | - | - | - | - | -73.57% | - |
Free Cash Flow Margin | -9.69% | -10.21% | -4.95% | -7.78% | 0.24% | 1.36% |
Free Cash Flow Per Share | -1.29 | -1.36 | -0.71 | -1.00 | 0.02 | 0.09 |
Cash Income Tax Paid | 30.75 | 32.75 | 20.01 | 32.79 | -13.67 | -6.64 |
Levered Free Cash Flow | -355.9 | -320.1 | -220.63 | -172.18 | -64.96 | -15.04 |
Unlevered Free Cash Flow | -355.9 | -320.1 | -214.36 | -168.86 | -62.2 | -13.4 |
Change in Working Capital | -17.52 | -17.52 | 66.63 | -71.06 | 71.4 | 17.6 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.